
Richard Kwon, MD, MS
Early detection of cancers in patients with pancreatic cystic neoplasms
Pancreatic cysts are still the only identifiable precursor lesions for pancreatic cancer, but today’s cross-sectional imaging and cyst-fluid analysis lack the accuracy to reliably identify cancer — which means missed cancers, or unnecessary tests and surgeries. Dr. Kwon and Dr. Carpenter developed a platform to tell malignant from benign mucinous cysts more accurately, combining quantitative image analysis (analytic morphomics, a process pioneered at Michigan) with primary culture of cyst fluid.
In October 2022 Dr. Carpenter opened her own lab to pursue new research projects; Dr. Kwon continues this project with his team.
Dr. Richard Kwon is an interventional endoscopist at the University of Michigan with expertise in endoscopic ultrasound and pancreatology. He is co-Director of the Comprehensive Pancreas Program, leads the Benign Pancreas Conference, and is active in the Multidisciplinary Pancreas Cancer Clinic and tumor board. His research centers on new ways to detect pancreatic cancer early.
Seed grants start at $50,000 — awarded by scientists, reported on annually.
Donate →
Richard Kwon, MD, MS
Early detection of cancers in patients with pancreatic cystic neoplasms
Pancreatic cysts are still the only identifiable precursor lesions for pancreatic cancer, but today’s cross-sectional imaging and cyst-fluid analysis lack the accuracy to reliably identify cancer — which means missed cancers, or unnecessary tests and surgeries. Dr. Kwon and Dr. Carpenter developed a platform to tell malignant from benign mucinous cysts more accurately, combining quantitative image analysis (analytic morphomics, a process pioneered at Michigan) with primary culture of cyst fluid.
In October 2022 Dr. Carpenter opened her own lab to pursue new research projects; Dr. Kwon continues this project with his team.
Dr. Richard Kwon is an interventional endoscopist at the University of Michigan with expertise in endoscopic ultrasound and pancreatology. He is co-Director of the Comprehensive Pancreas Program, leads the Benign Pancreas Conference, and is active in the Multidisciplinary Pancreas Cancer Clinic and tumor board. His research centers on new ways to detect pancreatic cancer early.
Seed grants start at $50,000 — awarded by scientists, reported on annually.
Donate →